While trying its hardest to become profitable, OpenAI is still falling massively short — and is even losing money on its pro ...

Flavored nitrous oxide is the newest drug to hit America's youth — and folks are developing startling side effects to it.

In a freewheeling interview with Bloomberg, OpenAI CEO Sam Altman took it out on the company's board members, who abruptly ...